Group-by-Treatment Interaction: FDA [General Sta­tis­tics]

posted by Helmut Homepage – Vienna, Austria, 2024-09-20 15:30 (81 d 23:15 ago) – Posting: # 24203
Views: 1,818

Dear all,

the FDA was definitely not happy with our article. Why am I not surprised?

Sun W , Alosh M, Schuirmann DJ, Grosser S. Letter to the Editor on “Group‑by‑Treatment Interaction Effects in Comparative Bio­avail­ability Studies”. AAPS J. 2024; 26(5): 101. doi:10.1208/s12248-024-00972-0.


Disclaimer The views expressed in this article represent the opinions of the authors, and do not represent the views and/or policies of the U.S. Food and Drug Administration.

At least.

Common procedure, e.g., in ‘Science’, ‘Statistics in Medicine’, ‘Journal of the American Statistical Association’, ‘Biometrics’, ‘British Medical Journals’ (a rant):
  1. An article is published.
  2. Some don’t agree, draft a ‘Letter to the Editor’, and submit it for review.
  3. If the editor deems it worthwhile, reviewers will be invited.
  4. If it is accepted, the authors of the publication are notified, provided with the accepted Letter, and given the opportunity to write a Rejoinder.
  5. The Letter is published together with the Rejoinder (not earlier).
  6. In some journals, both have even the same DOI so that interested readers are aware of both.
Since Rejoinders are not possible in the AAPS J, we will submit a ‘Letter’ responding to a ’Letter’… :-D

Edit: Rejoinder submitted on 6 October.

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
23,336 posts in 4,902 threads, 1,665 registered users;
32 visitors (0 registered, 32 guests [including 3 identified bots]).
Forum time: 13:46 CET (Europe/Vienna)

I’m all in favor of the democratic principle
that one idiot is as good as one genius, but I draw the line
when someone takes the next step and concludes
that two idiots are better than one genius.    Leo Szilard

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5